Literature DB >> 15281362

Synthesis and antiviral activities of new pyrazolo[4,3-c]quinolin-3-ones and their ribonucleoside derivatives.

Mara R P de Oliveira1, Thatyana R Alves, Angelo C Pinto, Helena de S Pereira, Luiz R Leão-Ferreira, Nissin Moussatché, Izabel Christina P P de Frugulhetti, Vitor F Ferreira, Maria Cecíla B V de Souza.   

Abstract

Several new pyrazolo[4,3-c]quinolin-3-one ribonucleosides (5a-g) and their corresponding heterocycle moieties (3a-g) were synthesized and evaluated against vaccinia virus (VV) and herpes simplex virus type 1 (HSV-1). The derivatives 3c and 3d showed modest inhibitory activity against vaccinia virus reaching 70% at a concentration of 100 microM. All heterocyclic compounds (3a-f) showed a modest inhibition against HSV-1, reaching the maximal inhibitory effect around 20-30%. The antiviral effects of most of the pyrazolo[4,3-c]quinolin-3-one ribonucleosides (5a-f) on VV and HSV were not impressive.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15281362     DOI: 10.1081/NCN-120038009

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  1 in total

1.  Synthesis and preliminary structure-activity relationship study of 2-aryl-2H-pyrazolo[4,3-c]quinolin-3-ones as potential checkpoint kinase 1 (Chk1) inhibitors.

Authors:  Ivana Malvacio; Alberto Cuzzolin; Mattia Sturlese; D Mariano A Vera; E Laura Moyano; Stefano Moro
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.